Glaukos
Breakthrough products and procedures to transform the treatment of glaucoma, one of the world’s leading causes of blindness. Learn more
Launch date
Employees
Market cap
$6.9b
Enterprise valuation
$6.8b (Public information from Sep 2024)
Share price
$130.07001 GKOS
Aliso Viejo California (HQ)
Authorizing premium user...